356 related articles for article (PubMed ID: 15011886)
1. Systemic humoral anti-Helicobacter pylori immune response in patients with gastric malignancies and benign gastroduodenal disease.
Manojlovic N; Nikolic L; Pilcevic D; Josifovski J; Babic D
Hepatogastroenterology; 2004; 51(55):282-4. PubMed ID: 15011886
[TBL] [Abstract][Full Text] [Related]
2. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
3. Anti Helicobacter pylori IgG and IgA response in patients with gastric cancer and chronic gastritis.
Manojlovic N; Babic D; Filipovic-Ljeshovic I; Pilcevic D
Hepatogastroenterology; 2008; 55(82-83):807-13. PubMed ID: 18613460
[TBL] [Abstract][Full Text] [Related]
4. Serological diagnosis of infection by Helicobacter pylori in chronic ulcer disease.
Kopański Z; Cienciała A; Słowakiewicz E; Witkowska B; Ulatowski Z
Mater Med Pol; 1993; 25(2):81-2. PubMed ID: 8072313
[TBL] [Abstract][Full Text] [Related]
5. The systemic cellular immune response in the Helicobacter pylori-associated duodenal ulcer and chronic antral gastritis.
Yuceyar H; Saruc M; Kokuludag A; Terzioglu E; Goksel G; Isisag A
Hepatogastroenterology; 2002; 49(46):1177-9. PubMed ID: 12143230
[TBL] [Abstract][Full Text] [Related]
6. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM
Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
[TBL] [Abstract][Full Text] [Related]
7. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection.
Schmausser B; Eck M; Greiner A; Lührs H; Vollmers HP; Müller-Hermelink HK
Virchows Arch; 2002 Aug; 441(2):143-7. PubMed ID: 12189503
[TBL] [Abstract][Full Text] [Related]
8. Th response to Helicobacter pylori differs between patients with gastric ulcer and duodenal ulcer.
Itoh T; Seno H; Kita T; Chiba T; Wakatsuki Y
Scand J Gastroenterol; 2005 Jun; 40(6):641-7. PubMed ID: 16036523
[TBL] [Abstract][Full Text] [Related]
9. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
10. Expression of class I and II MHC receptors in Helicobacter pylori-positive patients with active gastritis and duodenal ulcer.
Suleymanov Z
Turk J Gastroenterol; 2003 Sep; 14(3):168-72. PubMed ID: 14655059
[TBL] [Abstract][Full Text] [Related]
11. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
[TBL] [Abstract][Full Text] [Related]
12. Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer.
Atalay C; Atalay G; Altinok M
Neoplasma; 2003; 50(3):185-90. PubMed ID: 12937851
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibody against Helicobacter pylori.
Xiao SD; Pan ZJ; Zhang ZH; Jiang SJ
Chin Med J (Engl); 1991 Nov; 104(11):904-8. PubMed ID: 1800030
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa.
Lamarque D; Gilbert T; Roudot-Thoraval F; Deforges L; Chaumette MT; Delchier JC
Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):721-6. PubMed ID: 10445790
[TBL] [Abstract][Full Text] [Related]
15. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
16. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM
Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
[TBL] [Abstract][Full Text] [Related]
17. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease.
Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K; Okada H; Shiratori Y
Am J Gastroenterol; 2005 May; 100(5):1037-42. PubMed ID: 15842576
[TBL] [Abstract][Full Text] [Related]
18. A past history of gastric ulcers and Helicobacter pylori infection increase the risk of gastric malignant lymphoma.
Suzuki T; Matsuo K; Ito H; Hirose K; Wakai K; Saito T; Sato S; Morishima Y; Nakamura S; Ueda R; Tajima K
Carcinogenesis; 2006 Jul; 27(7):1391-7. PubMed ID: 16400189
[TBL] [Abstract][Full Text] [Related]
19. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
[TBL] [Abstract][Full Text] [Related]
20. Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases.
Sezikli M; Guliter S; Apan TZ; Aksoy A; Keles H; Ozkurt ZN
Int J Clin Pract; 2006 Oct; 60(10):1239-43. PubMed ID: 16669834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
